| Old Articles: <Older 33151-33160 Newer> |
|---|
 |
The Motley Fool
November 24, 2008
Kristin Graham |
How the Credit Crisis Stole Christmas The lack of credit is dramatically altering the holiday season for shoppers and for retailers.   |
The Motley Fool
November 24, 2008
Colleen Paulson |
The Land of Misfit Toys A new study gives its outlook on holiday toy spending, and it's not pretty. |
The Motley Fool
November 24, 2008
Kristin Graham |
Which Retailers Are Good Inventory Managers? Companies that keep inventory moving and respond to consumer trends have the best shot at weathering the storm. Take a look at a few companies with superior inventory management skills. |
The Motley Fool
November 24, 2008
Kristin Graham |
Who's the Most Adaptable Retailer? Not every retailer will survive till 2009. Here's one characteristic to look for before buying retail stocks this holiday season. |
The Motley Fool
November 24, 2008
Rick Aristotle Munarriz |
TiVo Still Firing at Satellites The three-year battle between TiVo and DISH Network rages on, with TiVo taking the latest punch. |
The Motley Fool
November 24, 2008
Dave Mock |
Verizon Rides Out the BlackBerry Storm The new BlackBerry Storm from Research In Motion may be the most effective iPhone killer yet. But how will it affect Verizon? |
The Motley Fool
November 24, 2008
David Lee Smith |
Sensible Stocks for an Absurd Market It makes sense to look at this pair of downtrodden oilfield service stocks. Let's review Schlumberger and Halliburton. |
The Motley Fool
November 24, 2008
Chris Jones |
Top of the Morning, Woodward Governor! Woodward Governor develops essential components for aerospace, transportation, and electrical generation industries, and has been running on all cylinders lately. |
The Motley Fool
November 24, 2008
Tim Beyers |
VMware Sniffs and Whiffs Virtualization toolmaker Transitive is now in IBM's hands, instead of VMware's. |
The Motley Fool
November 24, 2008
Brian Orelli |
Bristol Rolls Snake Eyes in Europe European officials reject Bristol-Myers Squibb's breast cancer treatment, Ixempra. |
| <Older 33151-33160 Newer> Return to current articles. |
